Paradigm Shift: PE Sellside Outweighs Buyside

The value of global private equity sales has topped the value of private equity purchases so far this year, according to data compiled by our Thomson Reuters colleagues.

It’s the first time that sellside volume ($67.2b) has topped buyside volume ($64.1b) since 1994, and was aided by today’s announced $4 billion sale of Talecris Biotherapeutics to Spain-based Grifols. The number of purchases, however, continues to outweigh the number of exits.

Overall, both buyside and sellside activity is up in 2010 over last year — by 132% and 174%, respectively.

You can download the full report here.